SynthesisPloS one2018

Comparative efficacy and safety of licensed treatments for previously treated non-small cell lung cancer: A systematic review and network meta-analysis.

Xavier Armoiry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.